Brief: Rallybio reports Q4 basic net loss per share of USD 0.46
06/03/2023 13:04
Mar 6 (Reuters) - Rallybio Q4 net income USD -16.203 million. * Q4 operating expenses USD 17.091 million * Q4 income from operations USD -17.091 million * Q4 basic EPS USD -0.46
Recent news on Rallybio
See all newsNASDAQ RESUMED AT 08:48 AM
Brief: Rallybio Corporation And Avenzo Therapeutics Announce Merger Agreement To Advance Next-Generation Oncology Therapies And $215 Million Concurrent Private Placement
NASDAQ TRADE HALT HALT NEWS PENDING AT 07:55 AM
U.S. STOCKS ON THE MOVE-Mirum Pharma
U.S. STOCKS ON THE MOVE-Mirum Pharma, eBay, FedEx